Chemours Stock News

The Chemours Company (NYSE:CC ) Q1 2023 Results Conference Call April 28, 2023 8:00 AM ET Company Participants Jonathan Lock - SVP and Chief Development Officer Mark Newman - CEO, President and Direct

While the top- and bottom-line numbers for Chemours (CC) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to

Chemours (CC) came out with quarterly earnings of $0.98 per share, beating the Zacks Consensus Estimate of $0.62 per share. This compares to earnings of $1.46 per share a year ago.

WILMINGTON, Del.--(BUSINESS WIRE)--The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solutions,

If the Covid-19 pandemic taught us anything, it's that investors should never underestimate the power of coordinated trading action via social media, which brings up the topic of super speculative mem

While Chemours (CC) is exposed to headwinds from higher raw material costs, it gains on healthy Opteon demand and its pricing actions.

Mark Newman, CEO of chemical company Chemours, joins Brian Sullivan and the 'CNBC Special: Taking Stock' to discuss how his company is working to expand the footprint of American manufacturing.

Chemours (CC) gains from increased prices across its segments amid headwinds from higher input cost inflation, adverse currency movements and soft demand in Europe & Asia in Q4.

The Chemours Company (NYSE:CC ) Q4 2022 Results Earnings Conference Call February 10, 2023 8:00 AM ET Company Participants Jonathan Lock - Senior Vice President and Chief Development Officer Mark Newm

While the top- and bottom-line numbers for Chemours (CC) give a sense of how the business performed in the quarter ended December 2022, it could be worth looking at how some of its key metrics compare

Chemours (CC) delivered earnings and revenue surprises of -100% and 5.93%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

WILMINGTON, Del.--( BUSINESS WIRE )--The Chemours Company (“Chemours”) (NYSE: CC), a global chemistry company with leading market positions in Titanium Technologies, Thermal & Specialized Solution

My coverage of Chemours Company has been extensive, and I consider the business an interesting one in the chemical space, trading at a massive sort of discount. There are good reasons for this discoun

There is a lot to like about The Chemours Company, but there is one issue that should give investors pause.

While Chemours (CC) is exposed to headwinds from higher raw material costs, it gains on healthy Opteon demand, strong execution and its cost-reduction and pricing actions.